Endogenous endophthalmitis with azole-resistant Candida albicans - Case report and review of the literature

Infection

Volumn 34, Issue 5, 2006, Pages 285-288

  Osthoff, M ^a   Hilge, R ^a   Schulze Dobold C ^a   Bogner, J R ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL SURGERY; ADULT; ANAMNESIS; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CASE REPORT; CLINICAL EXAMINATION; ENDOPHTHALMITIS; FEMALE; HUMAN; POSTOPERATIVE INFECTION; THERAPY RESISTANCE;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; ENDOPHTHALMITIS; EYE INFECTIONS, FUNGAL; FEMALE; HUMANS; MIDDLE AGED; VITRECTOMY;

EID: 33749845641     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-006-5119-3     Document Type: Article

References (32)

1. Binder MI, Chua J, Kaiser PK, Procop GW, Isada CM: Endogenous endophthalmitis. An 18-year review of culture-positive cases at a tertiary center. Medicine 2003; 82: 97-105.
2. Schiedler V, Scott IU, Flynn HW Jr, Davis JL, Benz MS, Miller D: Culture-proven Endogenous Endophthalmitis: Clinical Features and Visual Acuity Outcomes. Am J Ophthalmol 2004; 137:725-731.
3. Griffin JR, Pettit TH, Fishman LS, Foos RY: Blood-borne Candida endophthalmitis. A clinical and pathologic study of 21 cases. Arch Ophthalmol 1973; 89:450-456.
4. Edwards JE Jr, Foos RY, Montgomerie JZ, Guze LB: Ocular manifestations of Candida septicemia: review of seventy-six cases of hematogenous Candida endophthalmitis. Medicine (Baltimore) 1974; 53:47-75.
5. Henderson DK, Edwards JE, Montgomerie JZ: Hematogenous Candida endophthalmitis in patients receiving parental hyperalimentation fluids. J Infect Dis 1981; 143: 655-661.
6. Schelenz S, Gransden WR: Candidaemia in a London teaching hospital: analysis of 128 cases over a 7-year period. Mycoses 2003; 46: 390-396.
7. Bisbe J, Miro JM, Latorre X, Moreno A, Mallolas J, Gatell JM, de la Bellacasa JP, Soriano E: Disseminated candidiasis in addicts who use brown heroin: Report of 83 cases and review. Clin Infect Dis 1992; 15: 910-923.
8. Martinez-Vazquez C, Fernandez-Ulloa J, Bordon J, Sopena B, de la Fuente J, Ocampo A, Rubianes M: Candida albicans endophthalmitis in brown heroin addicts : response to early vitrectomy preceded and followed by antifungal therapy. Clin Infect Dis 1998; 27: 1130-1133.
9. Barza M: Editorial response: Treatment Options for Candidal Endophthalmitis. Clin Infect Dis 1998; 27: 1134-1136.
10. Brod RD, Flynn HW jr, Clarkson JG, Pflugfelder SC, Culbertson WW, Miller D: Endogenous Candida endophthalmitis. Management without intravenous amphotericin B. Opthalmology 1990; 97:666-672.
11. Akler ME, Vellend H, McNeely DM, Walmsley SL, Gold WL: Use of fluconazole in the treatment of candidal endophthalmitis. Clin Infect Dis 1995; 20: 657-664.
12. Green W, Bennett J, Goos R: Ocular penetration of Amphotericin B: a report of laboratory studies and a case report of postsurgical cephalosporium endophthalmitis. Arch Ophthalmol 1965; 73: 769-775.
13. Fisher J, Taylor A, Clark J, Rao R, Espinel-Ingroff A: Penetration of amphotericin B into the human eye. J Infect Dis 1983; 147:164.
14. O'Day D, Head W, Robinson R, Stern WH, Freeman JM: Intraocular penetration of systemically administered antifungal agents. Curr Eye Res 1985; 4: 131-134.
15. Tremblay C, Barza M, Szoka F, Lahav M, Baum J: Reduced toxicity of liposome-associated amphotericin B injected intravitreally in rabbits. Invest Ophthalmol Vis Sci 1985; 26: 711-718.
16. Barza M, Baum J, Tremblay C, Szoka F, D'Amico DJ: Ocular toxicity of intravitreally injected liposomal amphotericin B in rhesus monkeys. Am J Opthalmol 1985; 100: 259-263.
17. Axelrod A, Peyman G: Intravitreal amphotericin B treatment of experimental fungal endophthalmitis. Am J Ophthalmol 1973; 76: 584-588.
18. Donahue SP, Greven CM, Zuravleff JJ, Eller AW, Nguyen MH, Peacock JE Jr, Wagener MW, Yu VL: Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophthalmology 1994; 101: 1302-1309.
19. Goldblum D, Rohrer K, Frueh BE, Theurillat R, Thormann W, Zimmerli S: Ocular distribution of intravenously administered lipid formulations of amphotericin B in a rabbit model. Antimicrob Agents Chemother 2002; 46: 3719-3723.
20. Schmid S, Martenet AC, Oelz O: Candida endophthalmitis: clinical presentation, treatment and outcome in 23 patients. Infection 1991; 19: 21-24.
21. Savani DV, Perfect JR, Cobo LM, Durack DT: Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis. Antimicrob Agents Chemother 1987; 31: 6-10.
22. Tod M, Lortholary O, Padoin C, Chaine G: Intravenous penetration of fluconazole during endophthalmitis. Clin Microbiol Infect 1997; 3: 143-144.
23. del Palacio A, Cuetara MS, Ferro M, Perez-Blazquez E, Lopez-Sana JA, Roiz MP, Carnevali D, Noriega AR: Fluconazole in the management of endophthalmitis in disseminated candidosis of heroin addicts. Mycoses 1993; 36: 193-199.
24. Luttrull JK, Wan WL, Kubak BM, Smith MD, Oster HA: Treatment of ocular fungal infections with oral fluconazole. Am J Ophthalmol 1995; 119: 477-481.
25. Akler ME, Vellend H, McNeely DM, Walmsley SL, Gold WL: Use of fluconazole in the treatment of candidal endophthalmitis. Clin Infect Dis 1995; 20: 657-664.
26. Urbak SF, Degn T: Fluconazole in the management of fungal ocular infections. Ophthalmologica 1994; 208: 147-156.
27. Nomura J, Ruskin J: Failure of therapy with fluconazole for candidal endophthalmitis. Clin Infect Dis 1993; 17: 888-889.
28. Filler SG, Crislip MA, Mayer CL, Edwards JE Jr: Comparison of fluconazole and amphotericin B for treatment of disseminated candidiasis and endophthalmitis in rabbits. Antimicrob Agents Chemother 1991; 35: 288-292.
29. Breit SM, Hariprasad SM, Mieler WF, Shah GK, Mills MD, Grand MG: Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol 2005; 139: 135-140.
30. Martin D, Persat F, Piens MA, Picot S: Candida species distribution in bloodstream cultures in Lyon, France, 1998-2001. Eur J Clin Microbiol Infect Dis 2005; 24: 329-333.
31. Almirante B, Rodriguez D, Park BJ, Cuenca-Estrella M, Planes AM, Almela M, Mensa J, Sanchez F, Ayats J, Gimenez M, Saballs P, Fridkin SK, Morgan J, Rodriguez-Tudela JL, Warnock DW, Pahissa A: Barcelona Candidemia Project Study Group. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain from 2002 to 2003. J Clin Microbiol 2005; 43: 1829-1835.
32. Chryssantou E, Cherif H, Petrini B, Kalin M, Bjorkholm M: Surveillance of triazole susceptibility of colonizing yeasts in patients with haematological malignancies. Scand J Infect Dis 2004; 36: 855-859.